Hema Investors - HEMA Results Q3 FY17

Welcome to the HEMA Results Q3 FY17.

Topics

• Cash flow Q3 FY17

• Cost initiatives and EBITDA uplift potential

• Introduction

• Key macroeconomic indicators in the Netherlands

• Market developments in the Netherlands

• Q&A

• Results Q3 FY17

• Strategy update